UMIN-CTR Clinical Trial

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000019654
Receipt No. R000017291
Official scientific title of the study The effect of rich-hydrogen water drinking to gut peptide
Date of disclosure of the study information 2015/11/06
Last modified on 2017/11/06 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study The effect of rich-hydrogen water drinking to gut peptide
Title of the study (Brief title) The effect of rich-hydrogen water drinking to gut peptide
Region
Japan

Condition
Condition Parkinson's disease, healthy control
Classification by specialty
Medicine in general Neurology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To analysis the hemodynamic changes after drinking rich hydrogen water
Basic objectives2 Bio-availability
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2
Developmental phase Not applicable

Assessment
Primary outcomes the hemodynamic changes of gut peptide and inflammatory marker
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Cross-over
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Food
Interventions/Control_1 hydrogen water
Interventions/Control_2 natural water
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
80 years-old >
Gender Male and Female
Key inclusion criteria gut peptide
Key exclusion criteria diabetes mellitus
Target sample size 40

Research contact person
Name of lead principal investigator Masaaki Hirayama
Organization Nagoya graduate school of medicine university
Division name department of clinical laboratory science
Address 1-1-20 Daiko-Minami, Higashi-ku, Nagoya City, Aichi
TEL 052-719-1184
Email hirasan@med.nagoya-u.ac.jp

Public contact
Name of contact person Masaaki Hirayama
Organization Nagoya graduate school of medicine university
Division name department of clinical laboratory science
Address 1-1-20 Daiko-Minami, Higashi-ku, Nagoya City, Aichi
TEL 052-719-1184
Homepage URL
Email hirasan@med.nagoya-u.ac.jp

Sponsor
Institute Nagoya graduate school of medicine university
Institute
Department

Funding Source
Organization Nagoya graduate school of medicine university
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2015 Year 11 Month 06 Day

Progress
Recruitment status Preinitiation
Date of protocol fixation
2015 Year 11 Month 05 Day
Anticipated trial start date
2015 Year 11 Month 06 Day
Last follow-up date
2016 Year 11 Month 01 Day
Date of closure to data entry
2016 Year 11 Month 01 Day
Date trial data considered complete
2016 Year 11 Month 06 Day
Date analysis concluded
2016 Year 11 Month 06 Day

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2015 Year 11 Month 05 Day
Last modified on
2017 Year 11 Month 06 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000017291